We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reclassifies PTCA Catheters, Could Save Devicemakers Millions
FDA Reclassifies PTCA Catheters, Could Save Devicemakers Millions
September 10, 2010
In a move that could save devicemakers more than $1 million, the FDA is reclassifying standard percutaneous transluminal coronary angioplasty (PTCA) catheters as Class II devices with special controls.